Awarded TED · Source · Language: Deutsch

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8, 130c Abs. 1 SGB V zwischen der IKK classic und der Norgine GmbH zu Xolremdi (R)

IKK classic · Germany

View notices under this name

Official summary · Deutsch

What is being procured?

Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8, 130c Abs. 1 SGB V zwischen der IKK classic und der Norgine GmbH zu Xolremdi (R) (Wirkstoff: Mavorixafor, ATC-Code: L03AX24), Vertragslaufzeit: 01.09.2026-31.08.2028)

Deadline Not announced
Estimated valueNot announced
PublishedJul 14, 2026
Open official notice ↗

Notice history

Procurement timeline

Follow the main stages and updates linked to this procurement procedure.

No other related notice has been identified yet.

  1. Result notice Current notice

    · TED 484943-2026

    Open official notice ↗

Data is restructured for easier reading. The official notice and procurement documents always prevail.

Source and reliability

TED · 484943-2026. Checked on Aug 23, 2026, 4:05 PM.

Data is restructured for easier reading. The official notice and procurement documents always prevail.

Report an error by email